152
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Cell migration inducing hyaluronidase 1 (CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer

, &
Pages 145-152 | Received 14 Jan 2020, Accepted 14 Jul 2020, Published online: 05 Aug 2020

References

  • Tang J, Ren J, Cui Q, et al. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. J Cell Mol Med. 2019;23(10):6775–6784.
  • Parejo S, Tschan MP, Muraro MG, et al. Assessing autophagy during retinoid treatment of breast cancer cells. Methods Mol Biol. 2019;2019:237–256.
  • Yang Y, Li F, Luo X, et al. Identification of LCN1 as a potential biomarker for breast cancer by bioinformatic analysis. DNA Cell Biol. 2019;38(10):1088–1099.
  • DiNome ML, Orozco JIJ, Matsuba C, et al. Clinicopathological features of triple-negative breast cancer epigenetic subtypes. Ann Surg Oncol. 2019;26(10):3344–3353.
  • Bodoor K, Abu-Sheikha A, Matalka I, et al. Immunohistochemical analysis of heat shock proteins in triple negative breast cancer: HSP60 expression is a marker of poor prognosis. Eur J Gynaecol Oncol. 2018;39(6):2018.
  • Giuli MV, Giuliani E, Screpanti I, et al. Notch signaling activation as a hallmark for triple-negative breast cancer subtype. J Oncol. 2019;2019:8707053.
  • Richards R, Keating E, Boucher JE. Targeted therapies: treatment options for patients with metastatic breast cancer. Clin J Oncol Nurs. 2019;23(4):434–438.
  • Hsu JL, Hung MC. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev. 2016;35(4):575–588.
  • Miao X, Wang Z, Chen B, et al. miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3. Cell Mol Biol (Noisy-le-Grand). 2018;64(6):42–47.
  • Deroyer C, Charlier E, Neuville S, et al. CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes. Cell Death Dis. 2019;10(2):103.
  • Li L, Yan LH, Manoj S, et al. Central role of CEMIP in tumorigenesis and its potential as therapeutic target. J Cancer. 2017;8(12):2238–2246.
  • Lee HS, Jang CY, Kim SA, et al. Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer. Sci Rep. 2018;8(1):3383.
  • Shen F, Zong ZH, Liu Y, et al. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway. Biomed Pharmacother. 2019;114:108787.
  • Liang G, Fang X, Yang Y, et al. Silencing of CEMIP suppresses Wnt/β-catenin/Snail signaling transduction and inhibits EMT program of colorectal cancer cells. Acta Histochem. 2018;120(1):56–63.
  • Banach A, Jiang YP, Roth E, et al. CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia. Oncotarget. 2019;10(42):4307–4320.
  • Espinoza-Sanchez NA, Vadillo E, Balandran JC, et al. Evidence of lateral transmission of aggressive features between different types of breast cancer cells. Int J Oncol. 2017;51(5):1482–1496.
  • Li M, Li A, Zhou S, et al. Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer. BMC Cancer. 2018;18(1):4.
  • Sun W, Ge K, Jin Y, et al. Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis. ACS Nano. 2019;13(7):7556–7567.
  • Bastos DCA, Maldaun MVC, Sawaya R, et al. Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era. Neuro-Oncol Practice. 2018;5(3):161–169.
  • Ponde N, Wildiers H, Awada A, et al. Targeted therapy for breast cancer in older patients. J Geriatr Oncol. 2020;11(3):380–388.
  • Zhang P, Song Y, Sun Y, et al. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming. Faseb J. 2018;32(7):3924–3935.
  • Zhang D, Zhao L, Shen Q, et al. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer. Int J Cancer. 2017;140(10):2298–2309.
  • Liang G, Fang X, Yang Y, et al. Knockdown of CEMIP suppresses proliferation and induces apoptosis in colorectal cancer cells: downregulation of GRP78 and attenuation of unfolded protein response. Biochem Cell Biol. 2018;96(3):332–341.
  • Mazzio EA, Lewis CA, Soliman KFA. Transcriptomic profiling of MDA-MB-231 cells exposed to boswellia serrata and 3-O-acetyl-B-boswellic acid; ER/UPR mediated programmed cell death. Cancer Genom Proteoms. 2017;14(6):409–425.
  • Zhou Y, Pang B, Xiao Y, et al. The protective microRNA-199a-5p-mediated unfolded protein response in hypoxic cardiomyocytes is regulated by STAT3 pathway. J Physiol Biochem. 2019;75(1):73–81.
  • Yun S, Yun CW, Lee JH, et al. Cripto enhances proliferation and survival of mesenchymal stem cells by up-regulating JAK2/STAT3 pathway in a GRP78-dependent manner. Biomol Ther (Seoul)). 2018;26(5):464–473.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.